DrugPatentWatch Database Preview
Drugs in Development Information for ADX-10061
Email this page to a colleague
What is the development status for investigational drug ADX-10061?
ADX-10061 is an investigational drug.
There have been 12 clinical trials for ADX-10061.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.
The most common disease conditions in clinical trials are Narcolepsy, Syndrome, and Conjunctivitis. The leading clinical trial sponsors are Aldeyra Therapeutics, Inc., Jazz Pharmaceuticals, and Q32 Bio Inc.
There are three US patents protecting this investigational drug and one hundred and twenty-one international patents.
Summary for ADX-10061
| US Patents | 3 |
| International Patents | 121 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 2 (2015-05-01) |
| Vendors | 6 |
Recent Clinical Trials for ADX-10061
| Title | Sponsor | Phase |
|---|---|---|
| A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis | Aldeyra Therapeutics, Inc. | Phase 2 |
| A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19. | Aldeyra Therapeutics, Inc. | Phase 2 |
| A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC) | Aldeyra Therapeutics, Inc. | Phase 2 |
Clinical Trial Summary for ADX-10061
Top disease conditions for ADX-10061
Top clinical trial sponsors for ADX-10061
US Patents for ADX-10061
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ADX-10061 | Get Started Free | Pharmaceutical propylene glycol solvate compositions | McNeil-PPC, Inc. (Skillman, NJ) | Get Started Free |
| ADX-10061 | Get Started Free | Pharmaceutical co-crystal compositions | University of South Florida (Tampa, FL) The Regents of the University of Michigan (Ann Arbor, MI) Transform Pharmaceuticals, Inc. (Lexington, MA) | Get Started Free |
| ADX-10061 | Get Started Free | Fused benzazepines for treatment of stuttering | Psyadon Pharmaceuticals, Inc. (Germantown, MD) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ADX-10061
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ADX-10061 | Austria | AT550022 | 2022-02-15 | Get Started Free |
| ADX-10061 | Australia | AU2003211021 | 2022-02-15 | Get Started Free |
| ADX-10061 | Australia | AU2003213719 | 2022-02-15 | Get Started Free |
| ADX-10061 | Australia | AU2003243354 | 2022-02-15 | Get Started Free |
| ADX-10061 | Australia | AU2003243699 | 2022-02-15 | Get Started Free |
| ADX-10061 | Australia | AU2003267231 | 2022-02-15 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
